EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CF WHO ARE HOMOZYGOUS FOR Delta F508-CFTR: PHASE 3 TRAFFIC AND TRANSPORT STUDIES

Wainwright Claire E.; Elborn J. Stuart; Ramsey Bonnie; Huang Xiaohong; Marigowda Gautham; Waltz David; Boyle Michael P.

首页> 外文期刊>Pediatric Pulmonology >EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CF WHO ARE HOMOZYGOUS FOR Delta F508-CFTR: PHASE 3 TRAFFIC AND TRANSPORT STUDIES

【24h】

EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CF WHO ARE HOMOZYGOUS FOR Delta F508-CFTR: PHASE 3 TRAFFIC AND TRANSPORT STUDIES

机译：氟马考特联合依伐他汀对CF F相同的CF患者的影响：第三阶段交通和运输研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology 》 |2014年第38期| 共2页
作者
Wainwright Claire E.; Elborn J. Stuart; Ramsey Bonnie; Huang Xiaohong; Marigowda Gautham; Waltz David; Boyle Michael P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CF WHO ARE HOMOZYGOUS FOR Delta F508-CFTR: PHASE 3 TRAFFIC AND TRANSPORT STUDIES [J] . Wainwright Claire E., Elborn J. Stuart, Ramsey Bonnie, Pediatric Pulmonology . 2014 ,第Suppla38期

机译：氟马考特联合依伐他汀对CF F相同的CF患者的影响：第三阶段交通和运输研究
2. EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS WHO ARE HOMOZYGOUS FOR F508DEL-CFTR: TRANSPORT STUDY [J] . Ramsey B., Boyle M. P., Elborn J., Pediatric Pulmonology . 2014 ,第Suppla38期

机译：氟尿嘧啶与依伐他汀联合治疗对F508DEL-CFTR均具有同质性的囊性纤维化患者的运输研究
3. PHASE 2 STUDIES REVEAL ADDITIVE EFFECTS OF VX-661, AN INVESTIGATIONAL CFTR CORRECTOR, AND IVACAFTOR, A CFTR POTENTIATOR, IN PATIENTS WITH CF WHO CARRY THE Delta F508-CFTR MUTATION [J] . Pilewski Joseph M., Donaldson Scott H., Cooke Jon, Pediatric Pulmonology . 2014 ,第Suppla38期

机译：第2阶段研究了携带Delta F508-CFTR突变的CF患者的研究性CFTR矫正器VX-661和CFTR矫正剂IVACAFTOR的揭示性增效作用
4. Ivacaftor induces Pseudomonas aeruginosa population proteome changes in the airways of CF patients with G551D mutations [C] . Xia Wu, Katherine B. Hisert, Jayanthi Garudathri, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：Ivacafacter诱导铜绿假单胞菌蛋白酶蛋白质组蛋白质组变化，CF患者G551D突变患者
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Lumacaftor/ivacaftor combination for CF patients homozygous for Phe508del-CFTR [O] . Weiqiang Zhang, Xiaoying Zhang, Yanhui H. Zhang, -1

机译：Lumacaftor / ivacaftor组合用于纯合Phe508del-CFTR的CF患者
7. WS7.4 Lumacaftor, an investigational CFTR corrector, in combination with ivacaftor, a CFTR potentiator, in CF patients with the F508del-CFTR mutation: Phase 2 interim analysis [O] . Boyle M., Bell S.C., Konstan M., 2013

机译：WS7.4 Lumacaftor（一种研究性CFTR校正剂）与ivacaftor（一种CFTR增强剂）联合用于F508del-CFTR突变的CF患者：2期中期分析

EFFECT OF LUMACAFTOR IN COMBINATION WITH IVACAFTOR IN PATIENTS WITH CF WHO ARE HOMOZYGOUS FOR Delta F508-CFTR: PHASE 3 TRAFFIC AND TRANSPORT STUDIES

著录项

相似文献

相关主题

期刊订阅